tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Ranieri, 1235 are a BUY (49.72%), 1117 are a HOLD (44.97%), 132 are a SELL (5.31%).
Analyst Andrew Ranieri, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 37.5% that have a potential upside of 9.84% achieved within 30 days.
Andrew Ranieri’s has documented 180 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 09-Nov-2022.
Analyst best performing recommendations are on TMCI (TREACE MEDICAL CONCEPTS).
The best stock recommendation documented was for TMCI (TREACE MEDICAL CONCEPTS) at 5/26/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.43 (8.22%) receiving and performance score of 82.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
8 months 26 days ago
(26-Mar-2024)
1/5 (20%)
$4.31 (27.47%)
48
Buy
$10
$-0.05 (-0.50%)
$16
9 months 15 days ago
(07-Mar-2024)
3/5 (60%)
$0.09 (0.91%)
19
Sell
$11
$0.95 (9.45%)
$18
1 years 3 months 17 days ago
(05-Sep-2023)
1/3 (33.33%)
$2.29 (26.29%)
49
Hold
$13
$2.95 (29.35%)
$20
1 years 4 months 7 days ago
(15-Aug-2023)
0/5 (0%)
$1.86 (16.70%)
Buy
$13
$6.51 (100.31%)
$28
1 years 4 months 7 days ago
(15-Aug-2023)
1/3 (33.33%)
$4.47 (25.29%)
17
What Year was the first public recommendation made by Andrew Ranieri?
